Search research articles
Contact Us
Filters
Showing results (61-70 of 136) with videos related to
Page
of 14
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 26, 2013
A perspective on the prediction of drug pharmacokinetics and disposition in drug research and development
Li Di, Bo Feng, Theunis C Goosen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 3, 2020
Absorption and Disposition of Coproporphyrin I (CPI) in Cynomolgus Monkeys and Mice: Pharmacokinetic Evidence to Support the Use of CPI to Inform the Potential for Organic Anion-Transporting Polypeptide Inhibition
Xiaomei Gu, Lifei Wang, Jinping Gan, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
November 15, 2011
The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance
Katherine S Fenner, Hannah M Jones, Mohammed Ullah, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 15, 2012
Physicochemical property space of hepatobiliary transport and computational models for predicting rat biliary excretion
Manthena V S Varma, George Chang, Yurong Lai, et al.
Biopharmaceutics & Drug Disposition
|
April 10, 2016
Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment
Yaofeng Cheng, Chris Freeden, Yueping Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 20, 2018
Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition
Hong Shen, Lisa Christopher, Yurong Lai, et al.
Molecular Pharmaceutics
|
October 23, 2012
Characterization of organic anion transporting polypeptide (OATP) expression and its functional contribution to the uptake of substrates in human hepatocytes
Emi Kimoto, Kenta Yoshida, Larissa M Balogh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 23, 2017
Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition Assay
Ravindranath Reddy Gilibili, Sagnik Chatterjee, Pravin Bagul, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 3, 2025
Bridging in vitro and clinical data: Experimental insights into the IC<sub>50</sub> variability of dolutegravir as an organic cation transporter 2 inhibitor
Tomoki Koishikawa, Yukana Tomoda, Toshiaki Tsuchitani, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 21, 2022
Predicting changes in the pharmacokinetics of CYP3A-metabolized drugs in hepatic impairment and insights into factors driving these changes
Mayur K Ladumor, Flavia Storelli, Xiaomin Liang, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 136) with videos related to
Sort By:
Page
of 14
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 26, 2013
A perspective on the prediction of drug pharmacokinetics and disposition in drug research and development
Li Di, Bo Feng, Theunis C Goosen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 3, 2020
Absorption and Disposition of Coproporphyrin I (CPI) in Cynomolgus Monkeys and Mice: Pharmacokinetic Evidence to Support the Use of CPI to Inform the Potential for Organic Anion-Transporting Polypeptide Inhibition
Xiaomei Gu, Lifei Wang, Jinping Gan, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
November 15, 2011
The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance
Katherine S Fenner, Hannah M Jones, Mohammed Ullah, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 15, 2012
Physicochemical property space of hepatobiliary transport and computational models for predicting rat biliary excretion
Manthena V S Varma, George Chang, Yurong Lai, et al.
Biopharmaceutics & Drug Disposition
|
April 10, 2016
Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment
Yaofeng Cheng, Chris Freeden, Yueping Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 20, 2018
Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition
Hong Shen, Lisa Christopher, Yurong Lai, et al.
Molecular Pharmaceutics
|
October 23, 2012
Characterization of organic anion transporting polypeptide (OATP) expression and its functional contribution to the uptake of substrates in human hepatocytes
Emi Kimoto, Kenta Yoshida, Larissa M Balogh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 23, 2017
Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition Assay
Ravindranath Reddy Gilibili, Sagnik Chatterjee, Pravin Bagul, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 3, 2025
Bridging in vitro and clinical data: Experimental insights into the IC<sub>50</sub> variability of dolutegravir as an organic cation transporter 2 inhibitor
Tomoki Koishikawa, Yukana Tomoda, Toshiaki Tsuchitani, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 21, 2022
Predicting changes in the pharmacokinetics of CYP3A-metabolized drugs in hepatic impairment and insights into factors driving these changes
Mayur K Ladumor, Flavia Storelli, Xiaomin Liang, et al.
Page
of 14